Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial
ClinicalTrials.gov study NCT05942573. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibito
ClinicalTrials.gov study NCT05383001. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable P
ClinicalTrials.gov study NCT00139867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug
ClinicalTrials.gov study NCT01124747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
ClinicalTrials.gov study NCT02199925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
ClinicalTrials.gov study NCT04147910. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
ClinicalTrials.gov study NCT04347031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an Autoinjector
ClinicalTrials.gov study NCT06994936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladd
ClinicalTrials.gov study NCT01799499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease
ClinicalTrials.gov study NCT03034538. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study
ClinicalTrials.gov study NCT06786455. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects
ClinicalTrials.gov study NCT02147808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose of Labeled Cholesterol for Kinetics: A Pilot Study
ClinicalTrials.gov study NCT02065817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
ClinicalTrials.gov study NCT01131091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC
ClinicalTrials.gov study NCT03732274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leuk
ClinicalTrials.gov study NCT02225574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study That Will Test a Second Treatment Session of RZL-012.
ClinicalTrials.gov study NCT05763160. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Treatment Extension of Protocol MNTX 302
ClinicalTrials.gov study NCT01367613. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
ClinicalTrials.gov study NCT06745323. IPD Sharing: NO. Countries: 16. Publications: 0.
Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
ClinicalTrials.gov study NCT00559624. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.